BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Job Trends

  11 Companies Hiring Manufacturing Professionals Now

  Looking for a manufacturing job? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.

  January 15, 2026

   · 

  2 min read

   · 

  Angela Gabriel
• 

  Job Trends

  3 Top Challenges Facing Manufacturing Professionals Right Now

  The past year saw manufacturing challenges pushed into the spotlight. BioSpace spoke to two executives who shared key issues facing those working in this area, from finding the right providers to dealing with regulatory uncertainty.

  January 15, 2026

   · 

  6 min read

   · 

  Angela Gabriel
• 

  Rare diseases

  JPM Day 3: Rare Disease in the Spotlight

  2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for this year.

  January 15, 2026

   · 

  5 min read

   · 

  Tristan Manalac
• 

  Legal

  Compounder Sues Lilly, Novo, Claims Coordinated Crackdown

  Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers in exclusive partnerships, disallowing them from offering compounded versions of GLP-1 medicines.

  January 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate

  Half of the net proceeds will go to Jazz; it remains unclear who will get the remaining sum. Jazz did not reveal the buyer of the voucher.

  January 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug pricing

  Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’

  Incoming PhRMA Chair Paul Hudson, a day before the White House announcement, pledged to work with the administration as the president turns to insurers as a source of cost savings for prescription medicines.

  January 15, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  Editorial

  JPM26: Verizon Outage Unites Directionless Conference Goers

  It doesn’t matter how many times you have traversed Union Square; no one knows which way is north, or where The Westin is in relation to the Ritz Carlton. A Verizon outage brought that into focus on Wednesday of JPM week.

  January 15, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  FDA

  FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report

  Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite assurances of swift reviews under the FDA’s new Commissioner’s National Priority Voucher program.

  January 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Insights

  JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech

  Venture funds attending the J.P. Morgan Healthcare Conference said mounting funding pressures and Chinese competition have sharpened their focus on leadership qualities, from regulatory expertise and industry experience to the ability to scale—or step aside—as companies mature.

  January 15, 2026

   · 

  2 min read

   · 

  Jennifer C. Smith-Parker
• Press Releases

  C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways

  January 15, 2026

   · 

  10 min read